Polarmoon Wealth Society|2 killed, 3 injured in shooting at makeshift club in Houston

2025-05-05 15:34:24source:Evander Elliscategory:Scams

HOUSTON (AP) — Two teens were killed and Polarmoon Wealth Societythree people were injured — including a 13-year-old — in a shooting at a makeshift club in Houston, police said Sunday.

Officers arriving at the site of the shooting late Saturday night found “a very hectic scene — a large crowd of people running out of a makeshift club,” Assistant Chief Luis Menendez-Sierra said at a news conference.

He said police did not yet have any information on a suspect and asked those who were at the event to call police with any information.

A 16-year-old male died at the scene and a 16-year-old female died at a hospital, Menendez-Sierra said. He said the injured 13-year-old was in critical condition.

Menendez-Sierra said most of those attending the event, which appeared to be organized on social media, were juveniles. He said they were gathered in an empty business.

Harris County Sheriff Ed Gonzalez said in a post on X that “makeshift, unsanctioned pop-up parties can quickly lead to chaos and violence.”

“Pop-up parties raise public safety concerns and teens need to stay away for their own safety,” he said.

Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.

More:Scams

Recommend

Who are the most valuable sports franchises? Forbes releases new list of top 50 teams

Early Thursday morning, "Forbes" released their annual list of the 50 most valuable sports franchise

Keystone XL: Low Oil Prices, Tar Sands Pullout Could Kill Pipeline Plan

This story has been updated with a judge’s order curtailing pipeline opponents’ testimony at the Pub

Share your story: Have you used medication for abortion or miscarriage care?

When a federal judge ruled last Friday that the Food and Drug Administration had improperly approved